Page last updated: 2024-09-04

atazanavir sulfate and Nausea

atazanavir sulfate has been researched along with Nausea in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Babiker, A; Fox, L; Gey, D; Lopardo, G; Markowitz, N; Paton, N; Tavel, JA; Wentworth, D; Wyman, N	1
Laurence, J	1
De Marez, T; De Paepe, E; De Pauw, M; Hoetelmans, RM; Lefebvre, E; Sekar, VJ; Spinosa-Guzman, S; Vangeneugden, T	1

Reviews

1 review(s) available for atazanavir sulfate and Nausea

Article	Year
HIV therapeutics, continued: another HIV protease inhibitor approved. The AIDS reader, 2003, Volume: 13, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Approval; Drug Resistance, Viral; Headache; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Hypercholesterolemia; Nausea; Oligopeptides; Patient Selection; Pyridines; Treatment Outcome; United States; United States Food and Drug Administration; Viral Load	2003

Article

Year

HIV therapeutics, continued: another HIV protease inhibitor approved.

The AIDS reader, 2003, Volume: 13, Issue:8

Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Approval; Drug Resistance, Viral; Headache; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Hypercholesterolemia; Nausea; Oligopeptides; Patient Selection; Pyridines; Treatment Outcome; United States; United States Food and Drug Administration; Viral Load

2003

Trials

2 trial(s) available for atazanavir sulfate and Nausea

Article	Year
Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study. PloS one, 2010, Feb-23, Volume: 5, Issue:2 Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Furans; HIV Infections; Humans; Interleukin-2; Lopinavir; Male; Nausea; Oligopeptides; Opportunistic Infections; Organophosphates; Pyridines; Pyrimidinones; Ritonavir; Sulfonamides; Treatment Outcome	2010
Pharmacokinetics of darunavir (TMC114) and atazanavir during coadministration in HIV-negative, healthy volunteers. Drugs in R&D, 2007, Volume: 8, Issue:4 Topics: Adolescent; Adult; Area Under Curve; Atazanavir Sulfate; Chromatography, Liquid; Cross-Over Studies; Darunavir; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Male; Middle Aged; Nausea; Oligopeptides; Pyridines; Sulfonamides; Tandem Mass Spectrometry; Time Factors; Vomiting	2007

Article

Year

Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study.

PloS one, 2010, Feb-23, Volume: 5, Issue:2

Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Furans; HIV Infections; Humans; Interleukin-2; Lopinavir; Male; Nausea; Oligopeptides; Opportunistic Infections; Organophosphates; Pyridines; Pyrimidinones; Ritonavir; Sulfonamides; Treatment Outcome

2010

Pharmacokinetics of darunavir (TMC114) and atazanavir during coadministration in HIV-negative, healthy volunteers.

Drugs in R&D, 2007, Volume: 8, Issue:4

Topics: Adolescent; Adult; Area Under Curve; Atazanavir Sulfate; Chromatography, Liquid; Cross-Over Studies; Darunavir; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Male; Middle Aged; Nausea; Oligopeptides; Pyridines; Sulfonamides; Tandem Mass Spectrometry; Time Factors; Vomiting

2007